ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc
Authors
Keywords
-
Journal
Cancer Cell International
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-08
DOI
10.1186/s12935-020-01727-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elevated serum HER-2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression
- (2019) Hui Zheng et al. Cancer Medicine
- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- Combination of preoperative plasma fibrinogen and AJCC staging improves the accuracy of survival prediction for patients with stage I‐II gastric cancer after curative gastrectomy
- (2019) Peng Ding et al. Cancer Medicine
- Chemoresistance mechanisms of breast cancer and their countermeasures
- (2019) Xiwei Ji et al. BIOMEDICINE & PHARMACOTHERAPY
- Notch signaling in breast cancer: From pathway analysis to therapy
- (2019) B. Madhu Krishna et al. CANCER LETTERS
- Role of MEL-18 Amplification in Anti-HER2 Therapy of Breast Cancer
- (2018) Jeong-Yeon Lee et al. JNCI-Journal of the National Cancer Institute
- Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer
- (2018) Julia Y.S. Tsang et al. EBioMedicine
- Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance
- (2016) M. A. Miller et al. Cancer Discovery
- ADAM10: a new player in breast cancer progression?
- (2015) Maeve Mullooly et al. BRITISH JOURNAL OF CANCER
- Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 (CD44) and of Neuregulin-1 Requires Substrate Dimerization
- (2015) Monika Hartmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Distinct Intracellular Domain Substrate Modifications Selectively Regulate Ectodomain Cleavage of NRG1 or CD44
- (2015) Liseth M. Parra et al. MOLECULAR AND CELLULAR BIOLOGY
- The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain
- (2015) Paul Saftig et al. PROGRESS IN NEUROBIOLOGY
- The sheddase ADAM10 is a potent modulator of prion disease
- (2015) Hermann C Altmeppen et al. eLife
- ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer
- (2015) Katharina Feldinger et al. Oncotarget
- High HER2 Expression Correlates with Response to the Combination of Lapatinib and Trastuzumab
- (2014) Maurizio Scaltriti et al. CLINICAL CANCER RESEARCH
- ADAM10 Regulates Notch Function in Intestinal Stem Cells of Mice
- (2014) Yu-Hwai Tsai et al. GASTROENTEROLOGY
- CD44/Cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients
- (2013) Yuanyuan Cheng et al. MOLECULAR CARCINOGENESIS
- Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells
- (2012) Ming Qiu et al. CANCER LETTERS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Constitutive activation of metalloproteinase ADAM10 in mantle cell lymphoma promotes cell growth and activates the TNF /NF B pathway
- (2011) H. Armanious et al. BLOOD
- The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling
- (2011) S. Weber et al. DEVELOPMENT
- CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
- (2011) Michael O. Idowu et al. HUMAN PATHOLOGY
- A Disintegrin and Metalloproteinase 10 Regulates Antibody Production and Maintenance of Lymphoid Architecture
- (2011) Natalia S. Chaimowitz et al. JOURNAL OF IMMUNOLOGY
- Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL
- (2011) M L Sulis et al. LEUKEMIA
- A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice
- (2011) Ichiro Inoshima et al. NATURE MEDICINE
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- The Notch signaling pathway: Transcriptional regulation at Notch target genes
- (2009) T. Borggrefe et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- ADAM-10-Mediated N-Cadherin Cleavage Is Protein Kinase C- Dependent and Promotes Glioblastoma Cell Migration
- (2009) Z. A. Kohutek et al. JOURNAL OF NEUROSCIENCE
- Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor
- (2008) L. Witters et al. CANCER RESEARCH
- The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel
- (2008) Q.-Q. Li et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- ADAM10 is essential for proteolytic activation of Notch during thymocyte development
- (2008) L. Tian et al. INTERNATIONAL IMMUNOLOGY
- The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer
- (2008) Jessica Pruessmeyer et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started